Table 3.
Hypertension Prevalence Ratio (95% CI) |
Overweight/Obesity Prevalence Ratio (95% CI) |
Diabetes Prevalence Ratio (95% CI) |
|||||||
---|---|---|---|---|---|---|---|---|---|
Total (N = 41,717) | Males (n = 18,804) | Females (n = 22,913) | Total (N = 41,717) | Males (n = 18,804) | Females (n = 22,913) | Total (N = 41,717) | Males (n = 18,804) | Females (n = 22,913) | |
Europe | Reference | Reference | Reference | Reference | Reference | Reference | Reference | Reference | Reference |
South America | 0.89 (0.82–0.98) | 0.81 (0.70–0.94) | 0.95 (0.84–1.08) | 1.01 (0.97–1.07) | 1.04 (0.98–1.11) | 0.98 (0.91–1.06) | 1.16 (0.94–1.43) | 0.96 (0.70–1.30) | 1.32 (0.99–1.75) |
Mexico/C. Amer/ Carib | 1.24 (1.17–1.32) | 1.11 (1.01–1.22) | 1.34 (1.23–1.45) | 1.21 (1.17–1.25) | 1.15 (1.10–1.20) | 1.27 (1.21–1.34) | 1.84 (1.60–2.13) | 1.60 (1.31–1.94) | 2.04 (1.66–2.50) |
Russia | 1.16 (1.03–1.31) | 1.24 (1.04–1.48) | 1.08 (0.92–1.25) | 0.97 (0.88–1.08) | 1.00 (0.90–1.11) | 0.95 (0.80–1.12) | 0.82 (0.55–1.24) | 1.00 (0.59–1.70) | 0.66 (0.31–1.38) |
Africa | 1.29 (1.15–1.44) | 1.24 (1.06–1.45) | 1.29 (1.12–1.49) | 1.12 (1.06–1.18) | 1.00 (0.92–1.08) | 1.28 (1.18–1.39) | 1.71 (1.38–2.13) | 1.84 (1.38–2.46) | 1.46 (1.05–2.03) |
Middle East | 1.04 (0.92–1.17) | 1.16 (0.97–1.38) | 0.88 (0.74–1.04) | 1.01 (0.94–1.09) | 0.97 (0.89–1.07) | 1.04 (0.92–1.17) | 1.39 (1.07–1.82) | 1.87 (1.35–2.58) | 0.84 (0.50–1.43) |
Indian sub. | 1.04 (0.94–1.15) | 0.97 (0.84–1.13) | 1.07 (0.92–1.26) | 1.33 (1.27–1.38) | 1.23 (1.16–1.30) | 1.45 (1.35–1.54) | 2.26 (1.83–2.79) | 2.49 (1.91–3.24) | 1.85 (1.36–2.50) |
Asia | 0.94 (0.87–1.03) | 1.01 (0.89–1.14) | 0.89 (0.80–0.99) | 0.94 (0.89–0.99) | 1.05 (0.99–1.11) | 0.83 (0.76–0.90) | 0.97 (0.80–1.17) | 0.93 (0.69–1.26) | 1.00 (0.77–1.29) |
S.E. Asia | 1.30 (1.21–1.40) | 1.22 (1.09–1.37) | 1.36 (1.24–1.49) | 1.08 (1.04–1.12) | 1.12 (1.06–1.17) | 1.05 (0.99–1.12) | 1.76 (1.49–2.08) | 1.66 (1.32–2.08) | 1.83 (1.45–2.29) |
CI-Confidence Interval; Prevalence adjusted for age, poverty status, education, duration of US residence, doctor’s visit in past 12 months; Mexico/C. Amer/Carib = Mexico/Central America/Caribbean; Indian sub = Indian subcontinent; S.E. Asia; bold- p < 0.05